Barclays’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33M Buy
114,760
+34,812
+44% +$10M 0.01% 643
2025
Q1
$24.6M Buy
79,948
+5,212
+7% +$1.61M 0.01% 673
2024
Q4
$26.4M Buy
74,736
+16,142
+28% +$5.7M 0.01% 677
2024
Q3
$21M Sell
58,594
-15,445
-21% -$5.53M 0.01% 732
2024
Q2
$23.6M Sell
74,039
-16,832
-19% -$5.36M 0.01% 667
2024
Q1
$20.9M Sell
90,871
-16,201
-15% -$3.72M 0.01% 725
2023
Q4
$23.5M Buy
107,072
+11,750
+12% +$2.58M 0.01% 698
2023
Q3
$21.5M Buy
95,322
+6,915
+8% +$1.56M 0.01% 658
2023
Q2
$19.5M Buy
88,407
+44,715
+102% +$9.87M 0.01% 691
2023
Q1
$9.79M Buy
43,692
+12,931
+42% +$2.9M ﹤0.01% 813
2022
Q4
$8.55M Sell
30,761
-28,181
-48% -$7.84M ﹤0.01% 885
2022
Q3
$12.3M Buy
58,942
+39,850
+209% +$8.34M 0.01% 752
2022
Q2
$4.5M Sell
19,092
-824
-4% -$194K ﹤0.01% 1161
2022
Q1
$3.57M Buy
19,916
+4,846
+32% +$869K ﹤0.01% 1364
2021
Q4
$3.26M Sell
15,070
-45,308
-75% -$9.79M ﹤0.01% 1503
2021
Q3
$11.1M Buy
60,378
+20,259
+50% +$3.74M 0.01% 880
2021
Q2
$7.2M Buy
40,119
+23,493
+141% +$4.22M ﹤0.01% 1056
2021
Q1
$2.78M Buy
16,626
+9,579
+136% +$1.6M ﹤0.01% 1631
2020
Q4
$1.07M Sell
7,047
-2,756
-28% -$418K ﹤0.01% 1936
2020
Q3
$992K Sell
9,803
-6,027
-38% -$610K ﹤0.01% 1930
2020
Q2
$1.92M Sell
15,830
-1,431
-8% -$173K ﹤0.01% 1502
2020
Q1
$1.64M Sell
17,261
-173,988
-91% -$16.5M ﹤0.01% 1442
2019
Q4
$16.8M Buy
191,249
+177,195
+1,261% +$15.6M 0.01% 660
2019
Q3
$1.12M Sell
14,054
-19,073
-58% -$1.52M ﹤0.01% 2189
2019
Q2
$2.59M Buy
33,127
+12,591
+61% +$983K ﹤0.01% 1612
2019
Q1
$2.41M Sell
20,536
-1,920
-9% -$225K ﹤0.01% 1423
2018
Q4
$2.44M Sell
22,456
-16,904
-43% -$1.84M ﹤0.01% 1249
2018
Q3
$5.03M Buy
39,360
+15,749
+67% +$2.01M ﹤0.01% 1070
2018
Q2
$2.67M Sell
23,611
-15,391
-39% -$1.74M ﹤0.01% 1274
2018
Q1
$4.38M Sell
39,002
-3,638
-9% -$409K ﹤0.01% 970
2017
Q4
$6.31M Sell
42,640
-19,708
-32% -$2.92M 0.01% 789
2017
Q3
$7.31M Sell
62,348
-244,082
-80% -$28.6M 0.01% 670
2017
Q2
$39.8M Buy
306,430
+33,692
+12% +$4.37M 0.04% 210
2017
Q1
$36.9M Buy
272,738
+201,992
+286% +$27.3M 0.04% 203
2016
Q4
$10.1M Buy
70,746
+63,625
+893% +$9.13M 0.01% 502
2016
Q3
$840K Sell
7,121
-5,497
-44% -$648K ﹤0.01% 1496
2016
Q2
$1.34M Sell
12,618
-18,614
-60% -$1.97M ﹤0.01% 1294
2016
Q1
$3.47M Buy
31,232
+26,238
+525% +$2.91M 0.01% 834
2015
Q4
$780K Sell
4,994
-22,807
-82% -$3.56M ﹤0.01% 1467
2015
Q3
$3.64M Sell
27,801
-8,223
-23% -$1.08M ﹤0.01% 819
2015
Q2
$6.23M Buy
36,024
+15,110
+72% +$2.61M 0.01% 728
2015
Q1
$3.6M Sell
20,914
-9,776
-32% -$1.68M ﹤0.01% 1025
2014
Q4
$3.96M Buy
30,690
+13,827
+82% +$1.78M ﹤0.01% 1017
2014
Q3
$2.16M Sell
16,863
-58,490
-78% -$7.49M ﹤0.01% 1346
2014
Q2
$6.63M Buy
75,353
+28,734
+62% +$2.53M 0.01% 822
2014
Q1
$4.38M Buy
46,619
+5,397
+13% +$507K 0.01% 985
2013
Q4
$4.66M Sell
41,222
-32,097
-44% -$3.63M ﹤0.01% 1029
2013
Q3
$5.72M Sell
73,319
-65,327
-47% -$5.1M 0.01% 833
2013
Q2
$9.13M Buy
+138,646
New +$9.13M 0.01% 597